GlassScriptPhysician profile
Walter J Wofford
NPI 1790120160
$291.45
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.29 · 2020: $238 · 2021: $15.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $54.55 | 2020 | |
| Collegium Pharmaceutical, INC. | $46.28 | 2020 | |
| Arbor Pharmaceuticals, INC. | $32.88 | 2020 | |
| Scilex Pharmaceuticals INC. | $25.41 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.32 | 2020 | |
| Genentech USA, INC. | $18.84 | 2020 | |
| Neurocrine Biosciences, INC. | $15.42 | 2020 | |
| Medtronic, INC. | $15.32 | 2021 | |
| Merck Sharp & Dohme LLC | $14.98 | 2020 | |
| Sunovion Pharmaceuticals INC. | $14.58 | 2020 | |
| Boston Scientific Corporation | $12.88 | 2019 | |
| Biodelivery Sciences International, INC. | $11.75 | 2020 | |
| Forte Bio-Pharma LLC | $8.24 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Wofford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.